摘要 |
Inhibitors of HCV of formula (I), and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (1) with ritonavir are also provided. |
申请人 |
TIBOTEC PHARMACEUTICALS LTD.;MEDIVIR AB |
发明人 |
DE KOCK, HERMAN AUGUSTINUS;RABOISSON, PIERRE JEAN-MARIE BERNARD;SIMMEN, KENNETH ALAN;LINDSTROEM, MATS STEFAN;KAHNBERG, PIA CECILIA;ANTONOV, DMITRY;NILSSON, KARL MAGNUS;SAMUELSSON, BENGT BERTIL;ROSENQUIST, AASA ANNICA KRISTINA |